KESORAMIND Latest Share Price (KESORAMIND)
TODAY IN ONE LINE
With a market cap of ₹388.33 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
KESORAMIND flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Strong Price MomentumRobust returns of 481.6% over 1Y
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 100.0% YoY
- ●Promoter SellingPromoter holding decreased by 43.34% QoQ
Latest KESORAMIND News
What changed recently?
Recent events, corporate actions, and announcements.
KESORAMIND valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for KESORAMIND, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
KESORAMIND technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for KESORAMIND — derived from the latest tape, not yesterday's close.
KESORAMIND last traded at ₹12.3 with an intraday range of ₹12.3–₹13.24 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹12.30| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 14.81 | +2.51 | +20.38% |
| R3 | 13.87 | +1.57 | +12.74% |
| R2 | 13.55 | +1.25 | +10.19% |
| R1 | 12.93 | +0.63 | +5.09% |
| PIVOT | 12.61 | 0.31 | 2.55% |
| CURRENT | 12.30 | — | — |
| S1 | 11.99 | -0.31 | -2.55% |
| S2 | 11.67 | -0.63 | -5.09% |
| S3 | 11.05 | -1.25 | -10.19% |
| S4 | 10.11 | -2.19 | -17.83% |
KESORAMIND is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹–₹
Trading Below opening range, showing Bearishness
KESORAMIND financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for KESORAMIND — consolidated or standalone — with margins, YoY growth and key ratios inline.
KESORAMIND reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹388.33 Cr. and reported EPS of ₹-0.08.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 259 | 248 ▼ 4.3% |
| Sales Growth YoY %Derived | -93.51% | -4.30% |
| Other Income | 21 | 56 ▲ 170.7% |
| Total Income | 279 | 303 ▲ 8.6% |
| 120 | 143 ▲ 19.3% | |
| Gross ProfitDerived | 139 | 105 ▼ 24.6% |
| Gross Margin %Derived | 53.80% | 42.40% |
| 191 | 162 ▼ 15.2% | |
| EBITDA (Operating Profit)Derived | -52 | -57 ▼ 10.2% |
| OPM %Derived | -19.97% | -22.99% |
| 60 | 4 ▼ 94.1% | |
| Profit Before Tax (PBT) | -91 | -88 ▲ 3.1% |
| 19 | -0 ▼ 100.4% | |
| Effective Tax %Derived | -21.33% | 0.10% |
| Profit/Loss from Discontinued Ops | 5,766 | — ▼ 100.0% |
| Total Profit for Period | 5,655 | -88 ▼ 101.6% |
| Net Profit (Owner's PAT)Derived | 5,655 | -88 ▼ 101.6% |
| Net Profit Margin %Derived | 2,185.48% | -35.59% |
| PAT Growth YoY %Derived | 1,572.35% | -101.56% |
| Earnings Per Share (EPS ₹) | 182.03 | -2.84 ▼ 101.6% |
| Diluted Shares Outstanding (Cr) | 31 | 31 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -5 | 7 ▲ 239.4% |
| Total Expenses (incl. D&A & Interest) | 370 | 392 ▲ 5.7% |
| Material Cost % of RevenueDerived | 44.09% | 54.79% |
| Employee Cost % of RevenueDerived | 27.66% | 29.23% |
| Other Cost % of RevenueDerived | 46.11% | 36.16% |
| Interest Coverage (x)Derived | -3.01x | -3.24x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 3,996 | 4,202 ▲ 5.2% | 2,646 ▼ 37.0% | 2,653 ▲ 0.3% | 3,606 ▲ 35.9% | 3,778 ▲ 4.8% | 3,987 ▲ 5.5% | 259 ▼ 93.5% | 248 ▼ 4.3% | |
| Sales Growth YoY %Derived | — | 5.16% | -37.04% | 0.27% | 35.93% | 4.77% | 5.53% | -93.51% | -4.30% | |
| Other Income | 159 | 88 ▼ 44.6% | 40 ▼ 54.4% | 72 ▲ 78.8% | 37 ▼ 49.3% | 70 ▲ 92.0% | 49 ▼ 30.2% | 21 ▼ 58.1% | 56 ▲ 170.7% | |
| Total Income | 4,155 | 4,290 ▲ 3.3% | 2,686 ▼ 37.4% | 2,725 ▲ 1.4% | 3,642 ▲ 33.7% | 3,848 ▲ 5.7% | 4,036 ▲ 4.9% | 279 ▼ 93.1% | 303 ▲ 8.6% | |
1,317 | 1,333 ▲ 1.2% | 367 ▼ 72.4% | 359 ▼ 2.3% | 378 ▲ 5.4% | 430 ▲ 13.8% | 493 ▲ 14.6% | 120 ▼ 75.7% | 143 ▲ 19.3% | ||
| Gross ProfitDerived | 2,679 | 2,869 ▲ 7.1% | 2,278 ▼ 20.6% | 2,294 ▲ 0.7% | 3,228 ▲ 40.7% | 3,348 ▲ 3.7% | 3,494 ▲ 4.4% | 139 ▼ 96.0% | 105 ▼ 24.6% | |
| Gross Margin %Derived | 67.04% | 68.29% | 86.12% | 86.47% | 89.51% | 88.62% | 87.64% | 53.80% | 42.40% | |
2,753 | 2,668 ▼ 3.1% | 2,050 ▼ 23.2% | 1,918 ▼ 6.4% | 2,716 ▲ 41.6% | 3,077 ▲ 13.3% | 3,142 ▲ 2.1% | 191 ▼ 93.9% | 162 ▼ 15.2% | ||
| EBITDA (Operating Profit)Derived | -74 | 202 ▲ 372.8% | 228 ▲ 13.1% | 376 ▲ 64.4% | 512 ▲ 36.3% | 271 ▼ 47.2% | 352 ▲ 30.0% | -52 ▼ 114.7% | -57 ▼ 10.2% | |
| OPM %Derived | -1.85% | 4.80% | 8.63% | 14.16% | 14.20% | 7.16% | 8.82% | -19.97% | -22.99% | |
513 | 666 ▲ 29.7% | 456 ▼ 31.4% | 173 ▼ 62.1% | 591 ▲ 241.9% | 379 ▼ 35.8% | 576 ▲ 51.7% | 60 ▼ 89.6% | 4 ▼ 94.1% | ||
| Profit Before Tax (PBT) | -580 | -375 ▲ 35.2% | -188 ▲ 50.0% | -167 ▲ 11.0% | -87 ▲ 47.8% | -385 ▼ 341.2% | -274 ▲ 28.7% | -91 ▲ 66.8% | -88 ▲ 3.1% | |
-2 | -12 ▼ 497.5% | — ▲ 100.0% | -307 | -10 ▲ 96.8% | -191 ▼ 1830.4% | 110 ▲ 157.7% | 19 ▼ 82.3% | -0 ▼ 100.4% | ||
| Effective Tax %Derived | 0.35% | 3.18% | — | 183.93% | 11.32% | 49.51% | -40.06% | -21.33% | 0.10% | |
| Profit/Loss from Discontinued Ops | — | — | — | — | — | — | — | 5,766 | — ▼ 100.0% | |
| Total Profit for Period | -578 | -363 ▲ 37.1% | -188 ▲ 48.4% | 140 ▲ 174.7% | -77 ▼ 155.2% | -194 ▼ 151.2% | -384 ▼ 97.7% | 5,655 ▲ 1572.4% | -88 ▼ 101.6% | |
| Net Profit (Owner's PAT)Derived | -578 | -363 ▲ 37.1% | -188 ▲ 48.4% | 140 ▲ 174.7% | -77 ▼ 155.2% | -194 ▼ 151.2% | -384 ▼ 97.7% | 5,655 ▲ 1572.4% | -88 ▼ 101.6% | |
| Net Profit Margin %Derived | -14.45% | -8.65% | -7.09% | 5.28% | -2.14% | -5.14% | -9.63% | 2,185.48% | -35.59% | |
| PAT Growth YoY %Derived | — | 37.09% | 48.38% | 174.71% | -155.20% | -151.19% | -97.71% | 1,572.35% | -101.56% | |
| Earnings Per Share (EPS ₹) | -28.31 | -17.15 ▲ 39.4% | -8.85 ▲ 48.4% | 5.72 ▲ 164.6% | -3.16 ▼ 155.2% | -6.25 ▼ 97.8% | -12.36 ▼ 97.8% | 182.03 ▲ 1572.7% | -2.84 ▼ 101.6% | |
| Diluted Shares Outstanding (Cr) | 20 | 21 ▲ 3.8% | 21 ▲ 0.0% | 24 ▲ 15.6% | 24 ▼ 0.0% | 31 ▲ 26.9% | 31 ▲ 0.0% | 31 ▲ 0.0% | 31 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | -85 | -61 ▲ 28.5% | -16 ▲ 73.8% | 10 ▲ 163.5% | 2 ▼ 77.4% | 4 ▲ 92.2% | 6 ▲ 29.4% | -5 ▼ 184.3% | 7 ▲ 239.4% | |
| Total Expenses (incl. D&A & Interest) | 4,735 | 4,666 ▼ 1.5% | 2,874 ▼ 38.4% | 2,892 ▲ 0.6% | 3,730 ▲ 29.0% | 4,233 ▲ 13.5% | 4,310 ▲ 1.8% | 370 ▼ 91.4% | 392 ▲ 5.7% | |
| Material Cost % of RevenueDerived | 28.67% | 27.80% | 13.95% | 12.27% | 10.89% | 12.86% | 13.03% | 44.09% | 54.79% | |
| Employee Cost % of RevenueDerived | 10.29% | 8.46% | 8.30% | 8.13% | 5.09% | 5.81% | 5.70% | 27.66% | 29.23% | |
| Other Cost % of RevenueDerived | 58.60% | 55.02% | 69.19% | 64.19% | 70.23% | 75.65% | 73.11% | 46.11% | 36.16% | |
| Interest Coverage (x)Derived | -0.50x | 0.10x | 0.34x | 0.93x | 0.80x | 0.37x | 0.44x | -3.01x | -3.24x |
KESORAMIND segment analysis : revenue and profit mix.
Disclosed business segments at KESORAMIND with their share of revenue and profit, switchable between consolidated and standalone reporting.
KESORAMIND discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for KESORAMIND.
Our AI distills the core fundamental drivers supporting KESORAMIND, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
KESORAMIND's investment case rests on 2 positive markers and 9 flagged concerns drawn from the latest reported filings.
What you're getting.
Debt-to-equity ratio is relatively low at 0.58, suggesting manageable leverage compared to some highly indebted companies, which could offer some financial flexibility in the long term.
Promoter holding remains stable at 43.3%, indicating a significant commitment from the core management, which can be a positive sign for long-term strategic direction and stability.
Key Risks.
Kesoram consistently reports negative quarterly net profits of -25.9 and a deeply negative operating profit margin of -24.40%, highlighting severe operational inefficiencies and persistent financial losses.
Quarterly sales have declined by -6.03% and quarterly profits by -8.02%, reflecting a persistent negative trend in revenue generation and overall financial performance, raising significant concerns.
The stock trades near its 52-week low of 2.84, a drastic fall from its 52-week high of 235.98, highlighting extreme price volatility and deeply negative investor sentiment, impacting shareholder value.
FII holdings plummeted from 8.95% (Mar 2024) to 0.77% (Sep 2025), and DII holdings from 17.42% (Sep 2024) to 7.40% (Sep 2025), signaling a sharp decline in institutional investor confidence and support.
The Return on Capital Employed (ROCE) is significantly negative at -4.71%, demonstrating the company's inability to generate adequate returns from its invested capital, indicating poor efficiency.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.09. Balance sheet risk re-prices growth multiples fast.
KESORAMIND peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — KESORAMIND is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
KESORAMIND chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for KESORAMIND — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
KESORAMIND delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for KESORAMIND over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in KESORAMIND stood at 47.0% of traded volume, against a 20-day average of 59.6%.
KESORAMIND announcements: results, concalls, ratings, M&A.
Filings KESORAMIND sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
KESORAMIND files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 78 documents below.
General Updates
Kesoram Industries Limited has informed the Exchange about General Updates - Change in Control/Management of Cygnet Industries Limited, Wholly Owned…
Address Change
Kesoram Industries Limited has informed the Exchange regarding The Registered office of the Company is being shifted from 9/1 R.N. Mukherjee Road,…
Cessation
Kesoram Industries Limited has informed the Exchange regarding Cessation of Ms Jikyeong Kang as Non- Executive Director of the company w.e.f.…
Appointment
Kesoram Industries Limited has informed the Exchange regarding Appointment of Mr HHimanshu Ranjan as Non- Executive Independent Director of the…
Change in Company Secretary/Compliance Officer
Kesoram Industries Limited has informed the Exchange about Change in Company Secretary/Compliance Officer
KESORAMIND dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue KESORAMIND has declared, sequenced by announce and record date.
KESORAMIND corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About KESORAMIND: business, sector, key facts.
What KESORAMIND does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
KESORAMIND operates in the Other Textile Products industry under the Textiles sector, listed as NSE: KESORAMIND, BSE: 502937.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AKSHAR SPINTEX (AKSHAR) Share PricePeer
- ALOK INDUSTRIES (ALOKINDS) Share PricePeer
- AMBIKA COTTON MILL (AMBIKCO) Share PricePeer
- ASHIMA (ASHIMASYN) Share PricePeer
- AXITA COTTON (AXITA) Share PricePeer
- Top Losers TodayScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about KESORAMIND (KESORAMIND).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of KESORAMIND (KESORAMIND)?
The current share price of KESORAMIND (KESORAMIND) is ₹12.30. Today, the stock has declined by ₹0.64 (4.95%), trading in a range of ₹12.30 to ₹13.24. The stock opened at ₹13.07 with a trading volume of 74,77,517 shares.
02Is KESORAMIND stock a good investment for long-term?
KESORAMIND can be considered for long-term investment based on several factors. The company has a market capitalization of ₹388.33 Cr., P/E ratio of 0, ROE of -23.81%, and ROCE of -10.95%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of KESORAMIND stock?
The 52-week high price of KESORAMIND (KESORAMIND) is ₹14.26, while the 52-week low is ₹4.55. Currently trading at ₹12.30, the stock is 170.33% above its 52-week low and 13.74% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy KESORAMIND stock at the current price?
Whether to buy KESORAMIND stock at ₹12.30 depends on multiple factors. The stock is currently trading with a P/E ratio of 0 and P/B ratio of 0.98. Today's performance shows a loss of 4.95%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of KESORAMIND and when is the next dividend?
KESORAMIND offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹12.30, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of KESORAMIND?
KESORAMIND's key financial metrics include: P/E Ratio: 0, P/B Ratio: 0.98, ROE: -23.81%, ROCE: -10.95%, Dividend Yield: 0%, EPS: ₹-0.08, Book Value: ₹11.92, and Debt-to-Equity: 0.59. The company's market cap stands at ₹388.33 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is KESORAMIND stock performing today in the market?
KESORAMIND stock opened at ₹13.07 and is currently trading at ₹12.30, showing a decline of ₹0.64 (4.95%). The intraday high is ₹13.24 and low is ₹12.30. The trading volume stands at 74,77,517 shares, indicating strong market participation today.
08What is the P/E ratio of KESORAMIND and what does it indicate?
KESORAMIND has a Price-to-Earnings (P/E) ratio of 0, which means investors are willing to pay 0.00 for every ₹1 of earnings. With an EPS of ₹-0.08, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about KESORAMIND (KESORAMIND) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.